Letter Sequence Other |
---|
EPID:L-2017-PMP-0014, Shine Medical Technologies, Inc., Submittal of Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 (Open) |
Initiation
- Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request
- Acceptance...
Results
Other: ML18054A077, ML18087A340, ML18127B706, ML18128A034, ML18155A603, ML18162A117, ML18162A118, ML18162A129, ML18193A141, ML18268A344, ML18340A171, ML18340A276, ML19015A352, ML19071A185
|
MONTHYEARML18030A7422017-07-14014 July 2017 Irrevocable Standby Letter of Credit (Redacted) Project stage: Request ML18054A0772018-03-0808 March 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18092A0872018-03-27027 March 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18087A3892018-03-28028 March 2018 Meeting Slides for the April 3, 2018, Public Meeting Between Shine Medical Technologies. Inc. and the NRC Project stage: Request ML18162A0542018-03-28028 March 2018, 29 March 2018, 3 April 2018, 18 June 2018 Shine Medical Technologies, Inc. April 3, 2018 Public Meeting Project stage: Request ML18096A6882018-04-0303 April 2018 Confirmatory Action Letter (CAL) No. NRR-2011-001 Project stage: Request ML18096A4552018-04-0303 April 2018 Shine Operating License Pre-Application Meeting (Environmental Presentation Slides) Project stage: Request ML18087A3402018-04-0303 April 2018 Response to Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18096A6892018-04-0303 April 2018 Arrr Restart Plan (4/3/2018) Approach to Critical, Control Rod and Power Calibrations Project stage: Request ML18130A5782018-05-0707 May 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18162A1362018-05-11011 May 2018, 18 June 2018 Shine Medical Technologies, Inc. May 23, 2018 Public Meeting Project stage: Request ML18138A2912018-05-16016 May 2018 Shine Medical Technologies, Inc. - Submittal of Meeting Slides for the May 23 and 24, 2018 with NRC Project stage: Request ML18128A0342018-05-16016 May 2018 Response to Second Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18156A1302018-06-0101 June 2018 Inc. - Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18155A6032018-06-0707 June 2018 Response to Third Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18162A1172018-06-18018 June 2018 Shine Medical Technologies Acknowledgment of Receipt of 2016 Annual Financial Report Project stage: Other ML18162A0552018-06-18018 June 2018 Shine Medical Technologies April 3, 2018 Public Meeting Summary Project stage: Meeting ML18162A1162018-06-18018 June 2018 Shine Medical Technologies Annual Financial Report Project stage: Request ML18162A1182018-06-18018 June 2018 Shine Medical Technologies Response to Request for Withholding Letter for 2016 Annual Financial Report Project stage: Other ML18162A1292018-06-18018 June 2018 Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Periodic Reports on Construction Permit Conditions Project stage: Other ML18162A1382018-06-18018 June 2018 May 23-24, 2018, Summary of Meeting with Shine Medical Technologies, Inc Project stage: Meeting ML18127B7062018-06-21021 June 2018 Closure of NRC Confirmatory Action Letter No. NRR-2011-001 Project stage: Other ML18221A4532018-06-27027 June 2018, 17 August 2018 Shine Medical Technologies, Inc. June 2018 Public Meeting Project stage: Request ML18187A2162018-07-0202 July 2018 Resubmittal of Meeting Slides for the June 28, 2018, Public Meeting Between Shine Medical Technologies, Inc. and the NRC Project stage: Request ML18197A0802018-07-10010 July 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18193A1412018-07-16016 July 2018 Response to Fourth Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18277A1962018-07-17017 July 2018 Amendment to Standby Letter of Credit (Redacted) Project stage: Request ML18206A7262018-07-18018 July 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor (Redacted) Project stage: Request ML18221A4542018-08-17017 August 2018 Summary of Meeting with Shine Medical Technologies, Inc. Project stage: Meeting ML18239A2192018-08-27027 August 2018 Request for Confirmation of the 10 CFR Part 140 Financial Protection Requirements for the Shine Facility Project stage: Request ML18268A3442018-10-0202 October 2018 Letter of Appreciation for the Tour of the Research Test Reactor Fuel Fabrication Facility Provided to the U.S. Nuclear Regulatory Commission on August 21, 2018 EPID No. L-2017-PMP-0014 Project stage: Other ML18340A1712018-12-10010 December 2018 Shine Medical Technologies, Inc. - Acknowledgement of Receipt of Periodic Report on Construction Permit Conditions Project stage: Other ML18340A2762018-12-19019 December 2018 Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Request for Confirmation of Applicable Financial Protection Requirements Project stage: Other ML19025A2642019-01-22022 January 2019 Shine Medical Technologies, Inc. Submittal of Meeting Slides for the January 29 and 30, 2019 Meeting with the NRC Project stage: Request ML19024A3522019-01-22022 January 2019 Shine Medical Technologies - Meeting Slides for the January 31, 2019 Public Meeting Between Shine Medical Technologies, Inc. and the NRC Project stage: Request ML19025A2752019-01-22022 January 2019 Shine Medical Technologies, Inc. Submittal of Meeting Slides for the January 29 and 30, 2019 Meeting with the NRC Project stage: Request ML19015A3522019-02-15015 February 2019 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML19071A1852019-03-22022 March 2019 Shine Medical Technologies, Inc. - Request for Withholding from Public Disclosure Project stage: Other ML19071A1812019-03-22022 March 2019 Shine Medical Technologies, Inc. - January 31, 2019 Public Meeting Summary Project stage: Meeting ML19071A1792019-03-22022 March 2019 Shine Medical Technologies, Inc. January 31, 2019 Public Meeting Project stage: Request ML19071A1802019-03-22022 March 2019 Shine Medical Technologies, Inc. - Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance 2018-06-18
[Table View] |
|
---|
Category:Letter
MONTHYEARIR 05000228/20230012024-02-0505 February 2024 NRC Inspection Report 050-00228/2023-001, Disputed Cited Violation and Minor Violation Revised, EA-23-118 ML23279A1062023-10-0202 October 2023 Response to Violation 05000228/2023001-001B ML23255A0342023-09-0909 September 2023 Response to Violation 050-00228/2023-001-00lA ML23255A0362023-09-0909 September 2023 Response to Inspection Report 050-00228/2023-001 ML23219A1882023-08-24024 August 2023 NRC Inspection Report 05000228/2023001, and Notice of Violation ML23187A0562023-07-0101 July 2023 Radiation Safety Officer Change Update ML23187A0582023-07-0101 July 2023 July 1, 2022 Thru June 30, 2023 Summary of Changes, Tests, and Experiments ML23157A0662023-05-24024 May 2023 Letter from David Slaughter, Aerotest Operations, Inc. Inadequate Oversight of Non-Power Reactor OIG Case No. 21-012 and Requested Payment for Damages Caused by the Nrc'S Inadequate Oversight ML22361A1022023-02-24024 February 2023 Reactor Decommissioning Branch Project Management Changes for Some Decommissioning Facilities and Establishment of Backup Project Manager for All Decommissioning Facilities ML22340A0062022-11-16016 November 2022 Reference Documents from Decommissioning Plan ML22215A1522022-07-21021 July 2022 Aerotest Radiography and Research Reactor - AO RAI Responses for Decommissioning Plan ML22187A0852022-07-0101 July 2022 Inc - July 1, 2021 Thru June 30, 2022 Summary of Changes, Tests, and Experiments ML22152A2522022-06-28028 June 2022 Request for Additional Information on Review of Request for Amendment to Approve Decommissioning Plan, Arrr (License No. R-98, Docket No. 50-228) ML22060A2602022-03-21021 March 2022 Change in NRC Staff Project Management Responsibility for the Aerotest Radiography and Research Reactor ML22040A1992022-03-0909 March 2022 Examination Confirmation Letter No. 50-288/OL-22-03, Reed College ML22025A2002022-01-20020 January 2022 Amendment to AO Decommissioning Plan Submittal Letter Dated July 20, 2021, Agencywide Documents Access, and Management System (ADAMS) Accession No. ML21230A304 ML21307A3242022-01-12012 January 2022 Request for Supplemental Information for Decommissioning Plan, Arrr (License R-98, Docket 50-228) ML21344A0332022-01-0303 January 2022 Aerotest Letter from the Chief Financial Officer Regarding Additional Information for the Fees Assessed Under to Aerotest Operations, Inc. (Aerotest) within Invoice Number Lfb 22-0346 ML21361A0472021-12-21021 December 2021 Response to December 6, 2021 NRC Pol Issuance; the Licensee and Its Reactor Safeguard Committee Request a Reasonable Opportunity to Review and Address Short Comings of the Draft Licensee and Technical Specifications Along with the Draft Sa ML21242A4632021-12-0606 December 2021 Issuance of License Amendment No. 6 to Facility Operating License No. R-98 for the Aerotest Radiography and Research Reactor with Partial Denial of Amendment Request ML21307A1252021-10-28028 October 2021 Letter Regarding Charges Billed ML21209A5192021-07-20020 July 2021 Aerotest Radiography and Research Reactor, Response to NRC Letter Dated July 12, 2021 (ML21188A391) ML21230A3042021-07-20020 July 2021 Decommissioning Plan Submittal (Redacted) ML21147A3732021-07-19019 July 2021 Correction of Letters Regarding Closure of Confirmatory Action Letter No. NRR-04-003 and Review of Physical Security Plan ML21188A3912021-07-12012 July 2021 Inc. - Revised Completion Date Possession-Only License Amendment Request for the Aerotest Radiography and Research Reactor Facility Operating License ML21188A2162021-07-0101 July 2021 July 1, 2020 Through June 30, 2021 Summary of Changes, Tests, and Experiments ML21193A0892021-07-0101 July 2021 Emergency Plan (Redacted) ML21181A1232021-06-22022 June 2021 License and TS Amendments ML21147A0602021-05-19019 May 2021 Response to RAI 28 and 29 ML21056A3172021-04-30030 April 2021 CFO Response to Aerotest November 11 2020 Letter ML21126A1502021-04-28028 April 2021 License and TS Amendments ML21098A1572021-03-31031 March 2021 Response to RAI CFH Training and Requalification Program- 3/30/21 ML21118A0252021-03-30030 March 2021 Confirmatory Order ML21047A4682021-03-30030 March 2021 Request for Additional Information Possession-Only License Amendment Request for the Aerotest Radiography and Research Reactor Facility Operating License No. R-98 ML21034A6262021-03-12012 March 2021 Request for Additional Information Possession-Only License Amendment Request for the Aerotest Radiography and Research Reactor Facility Operating License No. R-098 ML21048A1392021-03-0505 March 2021 Acknowledgement of Letter Regarding Decommissioning Plan and Exercise of Enforcement Discretion ML21004A0792021-01-0707 January 2021 Review of Physical Security Plan in Support of Possession-Only License Amendment Request License No. R-98 ML20345A0312020-12-28028 December 2020 CFO Response to Aerotest November 2020 Letter Re Lfb 20-1849 IR 05000228/20202022020-12-10010 December 2020 U.S. Nuclear Regulatory Commission Security Inspection Report No. 05000228/2020202 and Notice of Violation - Non-OUO-SRI (Cover Letter) ML20332A0322020-11-18018 November 2020 Unable to Submit Decommissioning Plan by December 5, 2020 Due to COVID-19 ML20295A4242020-11-16016 November 2020 Notification of Mailing Address Change Regarding Submittal of Fingerprint Cards ML20325A1762020-11-11011 November 2020 Response to NRC CFO, Letter Dated April 18, 2019 Re Reimbursement Request for Activities Associated with the Fees That Were Not Performed in a Satisfactory Manner ML20325A1342020-11-10010 November 2020 Letter Disputing to Make Payment for Services That Are Not or Poorly Rendered ML20289A4772020-10-23023 October 2020 Aerotest Response Letter from D. Slaughter Dated September 14, 2020 Docket 50-228 ML20304A1532020-10-21021 October 2020 Response to Notice of Violation IR 05000228/20202012020-10-15015 October 2020 U.S. Nuclear Regulatory Commission Routine Inspection Report No. 05000228/2020201 and Notice of Violation ML20276A2472020-09-28028 September 2020 Aerotest Radiography and Research Reactor - Updated Arrr Security Plan ML20234A6312020-09-17017 September 2020 Request for Clarification Physical Security Plan Review - Cover Letter - (Public Version) ML20248H4602020-08-28028 August 2020 Inc - List of Explanations, Changes, and Justifications for Raj CFH Training and Requalification Program ML20177A2032020-07-27027 July 2020 Request for Additional Information Possession-Only License Amendment Request to Use Certified Fuel Handlers for the Aerotest Radiography and Research Reactor Facility Operating License No. R-98 2024-02-05
[Table view] |
Text
February 15, 2019 Dr. David M. Slaughter President and Reactor Administrator Aerotest Operations, Inc.
3455 Fostoria Way San Ramon, CA 94583
SUBJECT:
AEROTEST OPERATIONS, INC. - IRREVOCABLE STANDBY LETTER OF CREDIT FOR THE AEROTEST RADIOGRAPHY AND RESEARCH REACTOR (EPID NO. L-2017-PMP-0014)
Dear Dr. Slaughter:
Aerotest Operations, Inc. (Aerotest) holds U.S. Nuclear Regulatory Commission (NRC) Facility Operating License No. R-98 for the operation of the Aerotest Radiography and Research Reactor (ARRR). On February 28, 2017, the NRC issued an order and safety evaluation consenting to the indirect transfer of the ARRR license to Nuclear Labyrinth, LLC (Agencywide Documents Access and Management System (ADAMS) Accession Nos. ML16333A446, ML16333A448, and ML16333A449). The order (ADAMS Accession No. ML16333A448) stated that the approval of the transfer was subject to certain conditions, including a requirement that
[a] cash secured irrevocable standby letter of credit from a federally insured bank in the amount of $300,000 that conforms to the guidance provided in NRC Regulatory Guide 1.159 must be executed at the time of, or before, the transfer. NRC Regulatory Guide 1.159, Assuring the Availability of Funds for Decommissioning Nuclear Reactors, Revision 2, dated October 2011 (RG 1.159), may be found at ADAMS Accession No. ML112160012.
On July 14, 2017, an irrevocable standby letter of credit from Bank of the West, in the amount of
$300,000 (ADAMS Accession No. ML18030A742), was executed for the account of Aerotest, and an originally signed letter of credit was sent to the NRC by Bank of the West. The license transfer was subsequently consummated on July 17, 2017 (ADAMS Accession No. ML17138A310).
The NRC staff reviewed the letter of credit against the guidance in RG 1.159. RG 1.159 provides guidance to applicants and licensees of nuclear power, research, and test reactors concerning methods acceptable to the NRC staff for complying with requirements in the rules regarding the amount of funds for decommissioning, and also provides guidance on the content and form of the financial assurance mechanisms. RG 1.159, Section 2.3.1, states that a licensee may use the sample wording for an irrevocable standby letter of credit for a nuclear reactor licensee provided in RG 1.159, Appendix A-5. Although not specifically applicable to nuclear reactor licensees, NUREG-1757, Consolidated Decommissioning Guidance, Volume 3, Financial Assurance, Recordkeeping, and Timeliness, Revision 1, dated February 2012 (ADAMS Accession No. ML12048A683), was also consulted by the NRC staff to help inform its review, because NUREG-1757 provides additional guidance regarding decommissioning letters of credit, including letters of credit which deviate from standard wording. NUREG-1757,
D. Slaughter Section A.6.4, provides example wording for an irrevocable standby letter of credit for NRC licensees other than nuclear reactor licensees that is similar to the example wording in RG 1.159, and NUREG-1757, Appendix A, Checklist 6-B, provides a list of terms and conditions needed in decommissioning letters of credit that deviate from the example wording provided in NUREG-1757, Section A.6.4.
During its review, the NRC staff noted that Aerotests letter of credit, dated July 14, 2017, did not appear to adequately conform to certain guidance provided in RG 1.159. Therefore, by letter dated March 8, 2018 (ADAMS Accession No. ML18054A077), the NRC staff requested that Aerotest explain how it complies, or plans on complying, with the license transfer condition that the irrevocable standby letter of credit conforms to the guidance provided in NRC Regulatory Guide 1.159.
By letter dated July 18, 2018 (ADAMS Accession No. ML18206A726), Aerotest responded to the NRC staffs March 8, 2018, letter stating that Aerotest formally compl[ied] with the NRC
[l]etter by modifying the ARRRs letter of credit. On July 17, 2018, an amendment to Aerotests July 14, 2017, letter of credit was executed (ADAMS Accession No. ML18277A196) and an originally signed letter of credit amendment was sent to the NRC by Bank of the West.
The NRC staff reviewed Aerotests July 14, 2017, letter of credit, as amended on July 17, 2018, against the guidance in RG 1.159. As discussed above, the NRC staff used NUREG-1757, including NUREG-1757, Appendix A, Checklist 6-B, to inform its review of the letter of credits conformance with RG 1.159. The NRC staff noted that Aerotests amended letter of credit does not conform exactly with the NUREG-1757, Appendix A, Checklist 6-B, criterion that states [t]he letter of credit must be automatically renewed at each expiration date unless notification by certified mail is received by the NRC and the licensee at least 90 days prior to nonrenewal, because Aerotests amended letter of credit states that Bank of the West must at least ninety (90) days prior to the expiry date send written notice [of nonrenewal] by certified mail or courier service to both the beneficiary [(i.e., the NRC)] and applicant [(i.e., Aerotest)].
However, as noted above, NUREG-1757 is not applicable to nuclear reactor licensees. In addition, RG 1.159, Appendix A, states that licensees may add, delete, or modify sample provisions of the example wording for letters of credit and other instruments in RG 1.159, Appendix A, as their circumstances warrant, although licensees should ensure that the financial instruments comply with the NRCs decommissioning regulations. The relevant regulation in Title 10 of the Code of Federal Regulations (10 CFR) 50.75(1)(iii)(A)(1) states, in part, that a surety method (e.g., letter of credit) for decommissioning funding must be open-ended, or, if written for a specified term, such as 5 years, must be renewed automatically, unless 90 days or more prior to the renewal day the issuer notifies the NRC, the beneficiary, and the licensee of its intention not to renew. The NRC staff finds that, because it contains the condition that the bank must send notices of nonrenewal to the NRC and Aerotest by certified mail or courier service at least 90 days prior to the nonrenewal date, Aerotests letter of credit, as amended, complies with the relevant part of 10 CFR 50.75(1)(iii)(A)(1).
The NRC staff also finds that Aerotests letter of credit, as amended, adequately conforms to the other criteria listed in NUREG-1757, Appendix A, Checklist 6-B. Additionally, the NRC staff verified with the California Department of Business Oversight that Bank of the West is an entity that has the authority to issue a letter of credit, and whose letter of credit operations are regulated and examined by a State agency, as discussed in RG 1.159, Section 2.3.3(2).
Because Aerotests amended letter of credit conforms to the criteria in NUREG-1757, Appendix A, Checklist 6-B, or otherwise complies with relevant NRC regulations, and because the amended letter of credit is issued by an institution that conforms to the guidance in RG 1.159,
D. Slaughter Section 2.3.3(2), the NRC staff finds that Aerotests July 14, 2017, letter of credit, as amended on July 17, 2018, adequately conforms to the guidance provided in RG 1.159.
The NRC staff notes that Aerotests amended letter of credit lists the address for the NRC (i.e., the letter of credit beneficiary) as recommended in the example letter of credit in RG 1.159, Appendix A-5. However, the NRC staff further recommends that any documents or notifications related to Aerotest, but submitted directly from a bank to the NRC (i.e., not submitted by Aerotest pursuant to 10 CFR 50.4, Written communications) be sent to the attention of the NRC project manager for Aerotest. In addition, the NRC staff recommends that any submissions to the NRC include the related facility docket and license numbers.
The regulation in 10 CFR 50.75(1)(iii)(A)(2) requires that a decommissioning letter of credit be payable to a trust established for decommissioning costs, and the trustee and trust must be acceptable to the NRC. Aerotests amended letter of credit specifies that whenever the letter of credit is drawn on, the amount of the draft will be deposited directly into the standby trust fund of Aerotest. The NRC staff notes that, as discussed in RG 1.159, Section 2.3.2, documentation of such standby trust fund (in addition to an originally signed duplicate or conformed copy of the letter of credit) should be maintained in Aerotests records and be available for inspection by the NRC.
If you have any questions, please contact Edward Helvenston at 301-415-4067, or by electronic mail at Edward.Helvenston@nrc.gov.
Sincerely, R/A William Kennedy, Acting Chief Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation Docket No. 50-228 License No. R-98 cc: See next page
Aerotest Operations, Inc. Docket No. 50-228 California Energy Commission 1516 Ninth Street, MS-34 Sacramento, CA 95814 Radiologic Health Branch P.O. Box 997414, MS 7610 Sacramento, CA 95899-7414 Test, Research and Training Reactor Newsletter P.O. Box 118300 University of Florida Gainesville, FL 32611
ML19015A352 *concurred via email NRR-106 OFFICE NRR/DLP/PRLB/PM* NRR/DLP/PRLB/LA* NRR/DLP/PFPB* NMSS/DUWP/RTAB*
NAME EHelvenston NParker MDusaniwskyj RAugustus DATE 1/23/2019 1/16/2019 1/24/2019 1/24/2019 OFFICE OGC/NLO* NMSS/DUWP/RTAB/BC* NRR/DLP/PFPB/BC NRR/DLP/PRLB/ABC NAME JWachutka CMcKenney ABowers WKennedy DATE 2/12/2019 1/24/2019 2/13/2019 2/15/2019